Anaïs Girard-Gagnepain

Biochemistry, Genetics and Molecular Biology · Life Sciences

1h-index54citations18works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(11), Mechanisms of cancer metastasis(4), Cancer-related molecular mechanisms research(2), RNA modifications and cancer(2), Cancer Diagnosis and Treatment(2)

Publications18 total

Supplementary Figure 3 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Table 1 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Methods, Figure Legend from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Data from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 5 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 1 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 1 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 4 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 5 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 3 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Methods, Figure Legend from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 2 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Table 1 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Data from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 4 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
Supplementary Figure 2 from Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
2023Open Access
"Le Syndrome Coronaire Aigu avec élévation du segment ST en 2014 et 2015 dans le Libournais", analyse de la prise en charge depuis l’événement jusqu'à un an après la sortie de la cardiologie : étude observationnelle rétrospective au travers du Registre Aquitain de l'Infarctus du Myocarde (REANIM) et du Registre Aquitain de Cardiologie Interventionnelle (ACIRA)
2018
Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism
Cancer Research·2013· 54 cited

Frequent Co-authors

Ivan Mikaélian(17), Mouhannad Malek(17), Rudy Gadet(17), Jean Viallet(17), Amandine Garcia(17), Cédric Hesling(17), Germain Gillet(17), Philippe Gonzalo(17), Ruth Rimokh(17), Marc Billaud(17)